Recently, a subpopulation of TSPAN8+ myofibroblast-associated fibroblasts (myCAFs) has been identified as being associated with treatment resistance and poor survival rates in multiple breast cancer patient cohorts [140]. Here, TSPAN8 is linked to breast carcinoma.